Tower Research Capital (TRC)’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $73K | Buy |
6,413
+3,475
| +118% | +$39.6K | ﹤0.01% | 2641 |
|
|
2025
Q1 | $34.9K | Sell |
2,938
-11,947
| -80% | -$142K | ﹤0.01% | 2499 |
|
|
2024
Q4 | $280K | Buy |
14,885
+12,036
| +422% | +$227K | 0.01% | 1461 |
|
|
2024
Q3 | $64K | Sell |
2,849
-3,755
| -57% | -$84.4K | ﹤0.01% | 2580 |
|
|
2024
Q2 | $138K | Buy |
6,604
+5,306
| +409% | +$111K | ﹤0.01% | 2355 |
|
|
2024
Q1 | $19.1K | Sell |
1,298
-22,307
| -95% | -$328K | ﹤0.01% | 3043 |
|
|
2023
Q4 | $244K | Buy |
23,605
+22,717
| +2,558% | +$234K | ﹤0.01% | 1942 |
|
|
2023
Q3 | $6.98K | Sell |
888
-1,736
| -66% | -$13.6K | ﹤0.01% | 4527 |
|
|
2023
Q2 | $26.2K | Sell |
2,624
-8,480
| -76% | -$84.7K | ﹤0.01% | 3121 |
|
|
2023
Q1 | $99K | Buy |
11,104
+10,405
| +1,489% | +$92.8K | ﹤0.01% | 1879 |
|
|
2022
Q4 | $8K | Sell |
699
-9,336
| -93% | -$107K | ﹤0.01% | 4432 |
|
|
2022
Q3 | $131K | Buy |
10,035
+5,506
| +122% | +$71.9K | ﹤0.01% | 2312 |
|
|
2022
Q2 | $57K | Buy |
4,529
+2,403
| +113% | +$30.2K | ﹤0.01% | 2758 |
|
|
2022
Q1 | $30K | Sell |
2,126
-2,559
| -55% | -$36.1K | ﹤0.01% | 3154 |
|
|
2021
Q4 | $136K | Buy |
4,685
+1,950
| +71% | +$56.6K | ﹤0.01% | 2035 |
|
|
2021
Q3 | $82K | Sell |
2,735
-175
| -6% | -$5.25K | ﹤0.01% | 2570 |
|
|
2021
Q2 | $77K | Sell |
2,910
-686
| -19% | -$18.2K | ﹤0.01% | 2643 |
|
|
2021
Q1 | $112K | Buy |
3,596
+994
| +38% | +$31K | ﹤0.01% | 2507 |
|
|
2020
Q4 | $86K | Buy |
2,602
+814
| +46% | +$26.9K | ﹤0.01% | 2502 |
|
|
2020
Q3 | $62K | Buy |
+1,788
| New | +$62K | ﹤0.01% | 3444 |
|